glp-1 hsa Can Employers Design an HSA-qualified HRA to Reimburse Drugs? Noom Med - GLP-1 Medications

A: Gastrointestinal discomfort stands as the dominant adverse response of GLP-1 agonists, including mild nausea, transient vomiting, bloating, diarrhea or constipation, which mostly emerge within the initial 28 weeks of administration as the gastrointestinal tract adapts to delayed emptying effects

Thiele, "Evidence that Melanocortin Receptor Agonist Melanotan-II Synergistically Augments the Ability of Naltrexone to Blunt Binge-Like Ethanol Intake in Male C57BL/6J Mice," Alcohol

Plus, research shows it may have a positive effect on preventing heart disease, which is associated with ED

however, human safety profiles remain undefined